Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Tyris tx
Paterna, Spain
A
1-10 Employees
-
Key takeaway
Tyris is focused on advancing non-viral gene therapies, which could be relevant to the development of CAR-T cell therapies. Their innovative platform enhances DNA-based treatments, potentially offering safer and more effective options for disease control.
Reference
Core business
Tyris Tx - Enhancing DNA-based therapies further ahead
A groundbreaking platform that extends the reach of genetic treatments by combining unprecedented DNA optimisation with non-viral delivery.
Cancerappy
Bilbao, Spain
A
1-10 Employees
2019
Key takeaway
CancerAppy is a biotech company dedicated to advancing cancer treatment through the discovery and development of new therapeutic targets, including insights into Treg impact on tumor immune responses. Their innovative approach, which integrates artificial intelligence, aims to enhance the diagnosis and treatment of cancer, aligning with the growing interest in therapies like CAR-T cell therapy.
Reference
Core business
CancerAppy is a biotech focused on the discovery and development of new therapeutic targets, based on its own artificial intelligence methodology
Geistek Pharmaceuticals
Madrid, Spain
A
1-10 Employees
2020
Key takeaway
Geistek Pharmaceuticals is a prominent player in advanced therapies, emphasizing its expertise in clinical trials and research. Notably, they highlight Tecartus, an advanced therapy approved for treating mantle cell lymphoma, and Kymriah, which falls under gene therapy.
Reference
Core business
Home | We Bring Science To Life - Geistek Pharma
Geistek Pharmaceuticals is one of the biggest CRO in Spain. We offer clinical services, we help you find funding and develop your project.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Nanoligent
Cerdanyola del Vallès, Spain
A
1-10 Employees
-
Key takeaway
Nanoligent is focused on developing targeted drug therapies using advanced protein engineering and nanobiotechnology, which may enhance the effectiveness of treatments while reducing side effects. Their innovative approach targets CXCR4 to inhibit tumor growth and metastasis, indicating potential applications in oncology and beyond.
Reference
Core business
Nanoligent – A biotech company
Omniscope
Barcelona, Spain
A
11-50 Employees
2021
Key takeaway
Omniscope is focused on advancing healthcare through innovative technologies, particularly in the field of oncology. They specialize in immune repertoire profiling, utilizing TCR and BCR sequencing platforms to enhance the understanding of immune responses, which is crucial for developing effective CAR-T cell therapies.
Reference
Product
Design a cellular therapy
Omniscope - Sequence up to 1 million immune cells per clinical sample to discover disease signatures with TCR and BCR sequencing platforms. Experience the power of single-cell resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.
Integra Therapeutics
Barcelona, Spain
A
1-10 Employees
2020
Key takeaway
Integra Therapeutics is focused on developing next-generation gene writing tools that enhance the efficiency and safety of advanced therapies. Their commitment to innovative technologies aims to address critical medical needs, particularly in the treatment of genetic and oncological diseases.
Reference
Core business
Company - Integra therapeutics
COMPANY Expertise ingene writing Integra Therapeutics is a biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies. Advanced therapies are a pillar of the medicine of the future. Our lead technology is FiCAT, a best-in-class platform geared towards resolving the current limitations on gene writing: size, […]
Universal Diagnostics
Seville, Spain
A
11-50 Employees
2012
Key takeaway
The company is focused on transforming cancer into a preventable and curable disease through early detection methods, particularly for gastrointestinal cancers like colorectal cancer. Their innovative approach utilizes multi-omics and computational biology to identify unique DNA regions associated with various cancers, aligning with their vision of a future where cancer can be effectively managed and treated.
Reference
Core business
Universal DX — A future where cancer is curable
SunRock Biopharma S.L
Santiago de Compostela, Spain
A
1-10 Employees
2014
Key takeaway
SunRock is a biotech company focused on developing therapeutic antibodies for cancer, particularly targeting highly invasive tumors. Their work addresses urgent clinical needs in oncology, making it relevant to advancements in cancer treatment.
Reference
Core business
SunRock Biopharma | Oncology Antibodies
SunRock is a biotech company devoted to the development of antibodies against highly invasive tumors with an urgent clinical need in oncology.
3P Biopharmaceuticals
Noáin (Valle de Elorz)/Noain (Elortzibar), Spain
A
251-500 Employees
2006
Key takeaway
3P Biopharmaceuticals specializes in cell therapy, providing comprehensive services from development to market supply. Their expertise in autologous and allogeneic applications highlights their capability to support projects in CAR-T cell therapy.
Reference
Service
We are a Cell Therapy CDMO // 3P Biopharmaceuticals. It's within us.
As a fully integrated Cell Therapy CDMO, we offer services from discovery to drug substance & drug product development & manufacturing.
ONA Therapeutics
Barcelona, Spain
A
11-50 Employees
2019
Key takeaway
ONA Therapeutics is a biotech company focused on developing biopharmaceuticals that target advanced cancer, which may align with the innovative approaches seen in CAR-T cell therapy. Their specialization in therapeutic biologics and lipid metabolism could complement advancements in cancer treatment strategies.
Reference
Core business
HOME PAGE Ona Therapeutics - Ona Therapeutics
ONA Therapeutics is a biotech company, spin-off of ICREA and IRB, specializes in the discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer.
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T Cell Therapy industry in Spain, several key considerations emerge. Regulatory frameworks are crucial, as Spain adheres to stringent EU regulations governing cell and gene therapies, impacting product approval and market access. Companies must navigate complex reimbursement pathways, as the economic viability of these therapies is often scrutinized by health authorities. The competitive landscape in Spain includes both established pharmaceutical giants and innovative biotech startups, creating a dynamic environment for collaboration and competition. Challenges such as manufacturing scalability, patient access to therapies, and the high cost of production remain significant hurdles. However, the landscape also presents opportunities for growth, particularly with increasing investment in research and development, driven by Spain's strong academic institutions and clinical expertise in immunotherapy. Environmental concerns related to biomanufacturing processes and waste management are gaining attention, necessitating sustainable practices within the industry. Additionally, the global relevance of CAR-T therapies enhances Spain's position in the international market, attracting partnerships and collaborations with leading global firms. Understanding these aspects is essential for anyone looking to engage with the CAR-T Cell Therapy sector in Spain, as they shape the industry's future trajectory and impact on patient care.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Spain |
| Amount of fitting manufacturers | 135 |
| Amount of suitable service providers | 135 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2006 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of CAR-T Cell Therapy?
Start-Ups who are working in CAR-T Cell Therapy are Omniscope
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are Biotechnology, IT, Software and Services, Healthcare, Pharmaceuticals, Other
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.